End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
32,950
KRW
|
+1.38%
|
|
+5.27%
|
-3.09%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
80,312
|
90,001
|
177,973
|
229,596
|
199,905
|
124,121
|
Enterprise Value (EV)
1 |
97,053
|
92,716
|
191,208
|
247,434
|
229,002
|
149,484
|
P/E ratio
|
13.5
x
|
5.05
x
|
17.8
x
|
19.4
x
|
18.2
x
|
19.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.58
x
|
0.71
x
|
1.42
x
|
1.43
x
|
1.03
x
|
0.74
x
|
EV / Revenue
|
0.7
x
|
0.74
x
|
1.53
x
|
1.54
x
|
1.18
x
|
0.9
x
|
EV / EBITDA
|
7.44
x
|
6.01
x
|
10.2
x
|
12.9
x
|
13.1
x
|
10.5
x
|
EV / FCF
|
14.7
x
|
32.3
x
|
10.9
x
|
38.6
x
|
-36.6
x
|
32.7
x
|
FCF Yield
|
6.82%
|
3.09%
|
9.18%
|
2.59%
|
-2.73%
|
3.06%
|
Price to Book
|
1.31
x
|
1.21
x
|
3.61
x
|
4.93
x
|
3.81
x
|
2.29
x
|
Nbr of stocks (in thousands)
|
3,622
|
3,622
|
3,610
|
3,610
|
3,675
|
3,651
|
Reference price
2 |
22,174
|
24,850
|
49,300
|
63,600
|
54,400
|
34,000
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
139,267
|
126,057
|
124,928
|
160,296
|
193,401
|
166,722
|
EBITDA
1 |
13,044
|
15,429
|
18,825
|
19,123
|
17,436
|
14,209
|
EBIT
1 |
7,974
|
9,829
|
13,494
|
14,906
|
13,461
|
8,063
|
Operating Margin
|
5.73%
|
7.8%
|
10.8%
|
9.3%
|
6.96%
|
4.84%
|
Earnings before Tax (EBT)
1 |
7,365
|
23,857
|
12,600
|
14,892
|
12,948
|
6,695
|
Net income
1 |
5,856
|
17,839
|
9,948
|
11,726
|
10,622
|
5,951
|
Net margin
|
4.21%
|
14.15%
|
7.96%
|
7.32%
|
5.49%
|
3.57%
|
EPS
2 |
1,638
|
4,926
|
2,763
|
3,271
|
2,983
|
1,706
|
Free Cash Flow
1 |
6,617
|
2,869
|
17,551
|
6,417
|
-6,249
|
4,571
|
FCF margin
|
4.75%
|
2.28%
|
14.05%
|
4%
|
-3.23%
|
2.74%
|
FCF Conversion (EBITDA)
|
50.72%
|
18.6%
|
93.23%
|
33.56%
|
-
|
32.17%
|
FCF Conversion (Net income)
|
112.98%
|
16.08%
|
176.44%
|
54.73%
|
-
|
76.81%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
16,741
|
2,715
|
13,235
|
17,838
|
29,098
|
25,363
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.283
x
|
0.176
x
|
0.703
x
|
0.9328
x
|
1.669
x
|
1.785
x
|
Free Cash Flow
1 |
6,617
|
2,869
|
17,551
|
6,417
|
-6,249
|
4,571
|
ROE (net income / shareholders' equity)
|
10.4%
|
26.2%
|
16.1%
|
24.6%
|
22.1%
|
11.7%
|
ROA (Net income/ Total Assets)
|
5.47%
|
6.61%
|
9.56%
|
10.8%
|
9.21%
|
5.31%
|
Assets
1 |
107,117
|
269,715
|
104,052
|
108,183
|
115,323
|
111,990
|
Book Value Per Share
2 |
16,983
|
20,576
|
13,650
|
12,909
|
14,281
|
14,865
|
Cash Flow per Share
2 |
38.70
|
2,210
|
949.0
|
1,475
|
146.0
|
269.0
|
Capex
1 |
8,880
|
5,439
|
1,401
|
2,557
|
16,884
|
11,713
|
Capex / Sales
|
6.38%
|
4.31%
|
1.12%
|
1.6%
|
8.73%
|
7.03%
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.09% | 86.77M | | +17.09% | 66.18B | | +1.64% | 49.24B | | +16.70% | 41.72B | | +22.44% | 26.16B | | +12.92% | 19.75B | | +2.82% | 17.5B | | -23.54% | 15.63B | | -5.88% | 15.46B | | +2.52% | 15.43B |
Other Specialty Chemicals
|